Analyzing the Reported Prevalence of Heart Disease among United States Adults: Trends from the National Center for Health Statistics Database
Main Article Content
Abstract
Objective
This study aims to comprehensively analyze and elucidate the reported prevalence of heart disease among United States adults, utilizing data extracted from the National Center for Health Statistics database from 1999 to 2019.
Methods
We conducted a thorough analysis of the National Center for Health Statistics database to examine demographic and socioeconomic variables, such as age, gender, race, education, poverty level, geographic region, and metropolitan status, influencing heart disease prevalence among United States adults. The outcomes were concisely summarized using aggregate data from 1999-2019, delineating prevalence trends across all participants throughout these years. One-way Analysis of Variance was utilized for statistical analyses, assessing variations in heart disease prevalence across diverse demographic and socioeconomic categories.
Results
The study reported notable trends in age-specific prevalence, revealing distinct patterns across different age groups. The age-adjusted average reported heart disease prevalence for individuals aged 18 and over from 1999 to 2019 was 5.9%,. Within the 18-44 age group, prevalence started at 1.0% and increased notably across subsequent age brackets: 45-54 (4.3%), 55-64 (9.9%), 65-74 (16.8%), and 75 and older (24.4%). Adult men consistently had a higher prevalence (7.6%) than women (4.5%). Prevalence varied among racial groups, with the highest in American Indian or Alaska Native-only individuals (12.4%). Socioeconomic variables illustrated a robust association between lower educational attainment, poverty, and increased heart disease prevalence. Geographic and metropolitan status analyses unveiled significant regional and residential disparities in reported heart disease prevalence. Education-level analysis revealed a higher prevalence for lower education (9.1%) and a lower prevalence for higher education (6.1%). Significant differences were observed in each category (p < 0.001).
Conclusion
This study highlights epidemiological patterns and reports heart disease prevalence, stressing the urgency for targeted interventions and preventative measures. Results underscore the importance of addressing temporal patterns, demographic inequalities, and geographic disparities through strategic public health efforts.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Mutluer FO, Çeliker A. General Concepts in Adult Congenital Heart Disease. Balkan Med J. 2018;35(1):18-29. doi:10.4274/balkan medj.2017.0910
3. Dominick. The Economic and Societal Impact of Cardiovascular Disease. Bayer // Global. Published August 23, 2018. Accessed March 30, 2024. https://www.bayer.com/en/pharma/economic-and-societal-impact-cardiovascular-disease
4. Julia N. Heart Disease Statistics in the US (2024 Update) - CFAH. CFAH. Published January 11, 2024.Accessed March 28, 2024. https://cfah.org/heart-disease-statistics/
5. Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. J Am Coll Cardiol. 2019;74(20):2529-2532. doi:10.1016/j.jacc.2019.10.009
6. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association [published correction appears in Circulation. 2023 Feb 21;147(8):e622] [published correction appears in Circulation. 2023 Jul 25;148(4):e4]. Circulation. 2023;147( 8):e93-e621. doi:10.1161/CIR.0000000000001123
7. Cheng DCY, Climie RE, Shu M, Grieve SM, Kozor R, Figtree GA. Vascular aging and cardiovascular disease: pathophysiology and measurement in the coronary arteries. Front Cardiovasc Med. 2023;10 :1206156. Published 2023 Nov 28. doi:10.3389/fcvm.20 23.1206156
8. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115(12):3378-3384. doi:10.1172/JCI27196
9. Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018;34(5):575-584. doi:10.10 16/j.cjca.2017.12.005
10. Turk-Adawi K, Sarrafzadegan N, Fadhil I, et al. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol. 2018;15(2):10 6-119. doi:10.1038/nrcardio.2017.138
11. Shah NS, Molsberry R, Rana JS, et al. Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics [published correction appears in BMJ. 2020 Sep 3;370:m3380]. BMJ. 2020;370 :m2688. Published 2020 Aug 13. doi:10.1136/ bmj.m2688
12. Sidney S, Go AS, Jaffe MG, Solomon MD, Ambrosy AP, Rana JS. Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. JAMA Cardiol. 2019;4(12):1280-1286. doi:10.1001/jamacardio.2019.4187
13. Wang H, Chai K, Du M, et al. Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis. Circ Heart Fail. 2021;14(10): e008406.doi:10.1161/CIRCHEARTFAILURE.121.008406
14. Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J. 2010;18(12):598-602. doi:10.1007/s1 2471-010-0841-y
15. Walli-Attaei M, Joseph P, Rosengren A, et al. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study [published correction appears in Lancet. 2020 May 29;:] [published correction appears in Lancet. 2020 Aug 1;396(10247):312]. Lancet. 2020;396(102 44):97-109. doi:10.1016/S0140-6736(20)30543-2
16. Eberly LA, Shultz K, Merino M, et al. Cardiovascular Disease Burden and Outcomes Among American Indian and Alaska Native Medicare Beneficiaries. JAMA Netw Open. 2023;6(9):e2334923. Published 2023 Sep 5. doi:10.1001/jamanetworkopen.2 023.34923
17. He J, Zhu Z, Bundy JD, Dorans KS, Chen J, Hamm LL. Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018. JAMA. 2021;326(13):1286-1298. doi:10.1001/jama.2021.15187
18. Brown AF, Liang LJ, Vassar SD, et al. Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014. Ann Intern Med. 2018;168(8):541-549. doi:10.7326/M17-0996
19. Rosengren A, Smyth A, Rangarajan S, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019;7(6): e748-e760. doi:10.1016/S2214-109X(19)30045-2
20. Parcha V, Kalra R, Suri SS, et al. Geographic Variation in Cardiovascular Health Among American Adults. Mayo Clin Proc. 2021;96(7):1770-1781. doi:10.1016/j.m ayocp.2020.12.034
21. Tabb LP, Ortiz A, Judd S, Cushman M, McClure LA. Exploring the Spatial Patterning in Racial Differences in Cardiovascular Health Between Blacks and Whites Across the United States: The REGARDS Study. J Am Heart Assoc. 2020;9(9):e016556. doi:10.1161/JAHA .120.016556
22. Abdalla SM, Yu S, Galea S. Trends in Cardiovascular Disease Prevalence by Income Level in the United States. JAMA Netw Open. 2020;3(9):e2018150. Published 2020 Sep 1. doi:10.1001/jamanetworkopen.2020.18150
23. Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Medicine in Novel Technology and Devices. 2019 Dec 1;4:100025. doi:10.1016/j.medntd. 2019.100025
24. Kubota Y, Heiss G, MacLehose RF, Roetker NS, Folsom AR. Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. JAMA Intern Med. 2017;177(8):1165-1172. doi:10.1001/jamainternmed.2017.1877
25. Muncan B. Cardiovascular disease in racial/ethnic minority populations: illness burden and overview of community-based interventions. Public Health Rev. 2018;39:32. Published 2018 Dec 3. doi:10.1186/s40985-018-0109-4
26. Kershaw KN, Roux AV, Bertoni A, Carnethon MR, Everson-Rose SA, Liu K. Associations of chronic individual-level and neighbourhood-level stressors with incident coronary heart disease: the multi-ethnic study of atherosclerosis. J Epidemiol Community Health. 2015;69(2):136–141. doi: 10.1136/jec h-2014-204217.
27. Troxel WM, Matthews KA, Bromberger JT, Sutton-Tyrrell K. Chronic stress burden, discrimination, and subclinical carotid artery disease in African American and Caucasian women. Health Psychol. 2003;22(3):300–309. doi: 10.1037/0278-6133.22.3.300.
28. Hahn RA, Truman BI. Education Improves Public Health and Promotes Health Equity. Int J Health Serv. 2015;45(4):657-678. doi:10.117 7/0020731415585986
29. Magnani JW, Ning H, Wilkins JT, Lloyd-Jones DM, Allen NB. Educational Attainment and Lifetime Risk of Cardiovascular Disease. JAMA Cardiol. 2024;9(1):45-54. doi:10.1001/j amacardio.2023.3990
30. Sterpetti AV, Gabriele R, Iannone I, Sapienza P, Marzo LD. The role of education and information to prevent trends towards increase of cardiovascular mortality rates in Europe from 2015 TO 2019. Curr Probl Cardiol. 2024;49(3):102415. doi:10.1016/j.cp cardiol.2024.102415
31. Lemstra M, Rogers M, Moraros J. Income and heart disease: Neglected risk factor. Can Fam Physician. 2015;61(8):698-704.
32. Meneton P, Kesse-Guyot E, Méjean C, et al.. Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals. Int Arch Occup Environ Health. 2015;88(6):707-716. doi: 10.1007/s00 420-014-0997-7
33. Min YI, Anugu P, Butler KR, et al.. Cardiovascular disease burden and socioeconomic correlates: findings from the Jackson Heart Study. J Am Heart Assoc. 2017; 6(8):e004416. doi: 10.1161/JAHA.116.004416